Kidron Miriam 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Feb 11, 2025
Insider Transaction Report
Form 4
Kidron Miriam
DirectorChief Scientific Officer
Transactions
- Award
Common Stock
2025-02-11+74,000→ 1,074,666 total - Award
Common Stock
2025-02-11+52,000→ 1,126,666 total - Award
Common Stock
2025-02-11+66,667→ 1,193,333 total
Footnotes (3)
- [F1]Represents shares issued on settlement of performance stock units ("PSUs") previously granted on January 4, 2024 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.
- [F2]Represents shares issued on settlement of PSUs previously granted on January 2, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.
- [F3]Represents shares issued on settlement of PSUs previously granted on February 3, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.